Saiba Animal Health AG Signs Second Agreement with Boehringer Ingelheim

Pfäffikon (SZ) Switzerland 1st of February 2022: Saiba Animal Health AG announced the commencement of another collaboration with Boehringer Ingelheim, a global leader in animal health. The new partnership further enhances one of Saiba’s key business goals, which is to advance its technology and product candidates through strategic alliances with top-tier companies. Towards this end, the agreement announced today is the sixth with an industry leader since Saiba’s founding in 2014.

Dr. Gary T. Jennings, CEO of Saiba Animal Health AG commented, “After only a year of working together, I take satisfaction from the fact that Boehringer Ingelheim has chosen to expand our partnership with a second agreement. Obviously, both parties have been encouraged by the progress of our first collaboration and recognize that opportunity may present itself through further alliance. Furthermore, I view this as recognition of the potential for our technology and product candidates to address major unmet needs in veterinary medicine. The team at Saiba Animal Health is excited to be increasing our interactions with Boehringer Ingelheim, an innovative global player recognized for its R&D excellence.”

For further information, please contact

Saiba Animal Health AG
CH-8808 Pfäffikon (SZ),
Gary Jennings, PhD